Curbing Hormones' Effects In Obese Patients Could Aid Against Breast Cancer
Wednesday, December 3, 2008 - 14:21
in Health & Medicine
Results from cell culture studies suggest a class of anticancer compounds called EGFR inhibitors, largely written off for breast cancers, could be effective in obese patients. The hormones leptin and IGF-1 synergistically stimulate migration and invasion in breast cancer cells. EGFR inhibitors block this stimulation.
Read the whole article on Science Daily
More from Science Daily
Related
- Curbing hormones' effects in obese patients could aid against breast cancerMon, 1 Dec 2008, 17:36:29 EST
- Compounds could be new class of cancer drugsTue, 3 Feb 2009, 16:15:41 EST
- Meta-analyses of global trials finds in favor of aromatase inhibitorsThu, 11 Dec 2008, 16:57:26 EST
- Early breast cancer: LHRH agonists show considerable promiseTue, 7 Oct 2008, 19:35:58 EDT
- Test for hormones in blood not reflective of hormones in breast tissue; breast cancer riskWed, 22 Apr 2009, 10:44:53 EDT